Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 11;47(3):17. doi: 10.3892/ijmm.2021.4850

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Jiang et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Changes of GSK-3β and p-GSK-3β (Ser9) protein and mRNA expression in FLS of AA rats after siRNA treatment. (A) The changes of p-GSK-3β(Ser9) protein expression were observed by an immunofluorescence technique (×400); a, control group; b, model group, c, siRNA (NC) group, d, siRNA group. (B) Semiquantitative analysis of fluorescence intensity. (C) The changes of p-GSK-3β(Ser9) mRNA expression were observed by RT-qPCR. (D) The changes of GSK-3β and p-GSK-3β(Ser9) protein expression were observed by western blotting. (E) Semiquantitative analysis of p-GSK-3β(Ser9)/GSK-3β protein. ^##P<0.01 compared with the control group; ^*P<0.05 compared with the model group. Control, FLS of the normal group; Model, FLS of the AA model group. siRNA (NC), small interfering RNA negative control; siRNA, small interfering RNA; FLS, fibroblast-like synoviocytes; AA, adjuvant-induced arthritis; RT-qPCR, reverse transcription-quantitative PCR.